Merck's Keytruda drug was shown in a new study to help about 40 percent of advanced melanoma patients stay alive for three more years. Former U.S. president Jimmy Carter used the medication after he was diagnosed with cancer last year.
Jimmy Carter's Immune Drug Keytruda Helps Cancer Patients Live Three Years Longer
Tech Times - 19 May 2016 13:31
Merck's Keytruda drug was shown in a new study to help about 40 percent of advanced melanoma patients stay alive for three more years. Former U.S. president Jimmy Carter used the medication after he was diagnosed with cancer last year.
Share this Article
Recommended